Attenuation of White Matter Damage Following Deferoxamine Treatment in Rats After Spinal Cord Injury. 2020

Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
Department of Neurosurgery, Southwest Hospital, Army Medical University, Chong'qing, China.

With little information available on axonal and myelin damage surrounding the contusion, the study of spinal cord injury (SCI) so far has focused on neuronal death. In this study, we investigated the role of iron overload in long-term oligodendroglia death and progressive white matter damage to rats after SCI using the iron chelator, deferoxamine (DFX). Female Sprague-Dawley rats received either a contusion at T10 or sham-surgery. The rats were treated with DFX or vehicle. All rats were evaluated in behavioral assessments and then euthanized at different time points. Spinal cords were analyzed by diaminobenzidine-enhanced Perls' staining, non-heme iron measurements, Western blotting, immunohistochemistry, and transmission electron microscopy. Iron accumulation after SCI resulted in the upregulation of transferrin receptor and divalent metal transporter 1, which exacerbated the intracellular iron overload. DFX treatment reduced iron overload-induced delayed oligodendrocyte death (e.g., 21 days: 47.12 ± 10.5 vs. 20.02 ± 9.4 x 103/mm2 in the vehicle-treated group, n = 4, P < 0.05). After SCI, the markers of axonal damage and demyelination were increased in white matter in the vehicle-treated group compared with the DFX-treated group (P < 0.05). Iron overload plays an important role in progressive white matter damage after SCI. DFX may be an effective treatment for white matter damage after SCI.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009836 Oligodendroglia A class of large neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system. Interfascicular Oligodendroglia,Oligodendrocytes,Perineuronal Oligodendroglia,Perineuronal Satellite Oligodendroglia Cells,Perivascular Oligodendroglia,Satellite Cells, Perineuronal, Oligodendroglia,Perineuronal Satellite Oligodendrocytes,Interfascicular Oligodendroglias,Oligodendrocyte,Oligodendrocyte, Perineuronal Satellite,Oligodendrocytes, Perineuronal Satellite,Oligodendroglia, Interfascicular,Oligodendroglia, Perineuronal,Oligodendroglia, Perivascular,Perineuronal Satellite Oligodendrocyte,Satellite Oligodendrocyte, Perineuronal,Satellite Oligodendrocytes, Perineuronal
D011990 Receptors, Transferrin Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released. Transferrin Receptors,Transferrin Receptor,Receptor, Transferrin
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013119 Spinal Cord Injuries Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.). Myelopathy, Traumatic,Injuries, Spinal Cord,Post-Traumatic Myelopathy,Spinal Cord Contusion,Spinal Cord Laceration,Spinal Cord Transection,Spinal Cord Trauma,Contusion, Spinal Cord,Contusions, Spinal Cord,Cord Contusion, Spinal,Cord Contusions, Spinal,Cord Injuries, Spinal,Cord Injury, Spinal,Cord Laceration, Spinal,Cord Lacerations, Spinal,Cord Transection, Spinal,Cord Transections, Spinal,Cord Trauma, Spinal,Cord Traumas, Spinal,Injury, Spinal Cord,Laceration, Spinal Cord,Lacerations, Spinal Cord,Myelopathies, Post-Traumatic,Myelopathies, Traumatic,Myelopathy, Post-Traumatic,Post Traumatic Myelopathy,Post-Traumatic Myelopathies,Spinal Cord Contusions,Spinal Cord Injury,Spinal Cord Lacerations,Spinal Cord Transections,Spinal Cord Traumas,Transection, Spinal Cord,Transections, Spinal Cord,Trauma, Spinal Cord,Traumas, Spinal Cord,Traumatic Myelopathies,Traumatic Myelopathy
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017262 Siderophores Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (The Encyclopedia of Molecular Biology, 1994) Siderophore,Siderochromes

Related Publications

Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
October 2010, Journal of neurotrauma,
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
June 2023, Molecular neurobiology,
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
November 2021, Journal of neurology, neurosurgery, and psychiatry,
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
April 2006, Brain pathology (Zurich, Switzerland),
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
March 2005, Anesthesia and analgesia,
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
August 2010, PloS one,
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
September 2000, Neuroscience letters,
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
October 2015, Experimental neurology,
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
April 2014, Zhonghua yi xue za zhi,
Jiantao Shi, and Rongrui Tang, and Yi Zhou, and Jishu Xian, and Chenghai Zuo, and Long Wang, and Jie Wang, and Hua Feng, and Shengli Hu
May 2010, Neurobiology of disease,
Copied contents to your clipboard!